Publication | Open Access
Low Level FLT3LG is a Novel Poor Prognostic Biomarker for Cervical Cancer with Immune Infiltration
12
Citations
31
References
2022
Year
Research on FLT3LG provided insight into its critical function. Hence, the low expression of FLT3LG may be a valuable biomarker in CESC patients linked with immune infiltration.
| Year | Citations | |
|---|---|---|
Page 1
Page 1